Brant Point's Strategic Cuts
Brant Point Investment Trims Holdings in Five Companies, Other Institutions Increase Stakes
Anonymous
Key Points
1
In Brink’s, Brant Point disclosed it ended the quarter with 18,502 shares worth about $2.16 million after selling 5,000 shares, even as Weiss Ratings downgraded the stock from a “hold (c+)” to a “hold (c)” on June 8.
2
Brant Point’s Brink’s filing coincided with bullish and bearish analyst moves: Wall Street Zen upgraded Brink’s from “buy” to “strong-buy,” and Goldman Sachs raised its price target from $129 to $145 while reiterating a “buy” rating.
3
For Saia, Brant Point reduced its position to 14,000 shares (worth about $4.571 million) after selling 1,447 shares, while multiple analysts updated targets in late spring/early summer—e.g., Susquehanna lifted its target to $465 but kept a “neutral” rating and JPMorgan raised its target to $490 with an “overweight” rating.
4
In Acadian Asset Management, Brant Point cut its stake to 30,000 shares after selling the same number of shares (30,000), and the article notes 98.69% of the stock is held by hedge funds and other institutional investors—context for how concentrated institutional ownership is even after the reduction.
5
In NiCE, Brant Point ended with 5,000 shares worth about $565,000 after selling 7,958 shares, but other institutional buying was pronounced, including Migdal Insurance & Financial Holdings’ stake increase of 0.9% to 1,646,690 shares (worth about $186.1 million).
Brant Point Investment Management trimmed its stakes in at least five public companies in its latest quarterly filings, cutting its position in Brink's (BCO) by 21% and SS&C Technologies (SSNC) by about a third, according to Ticker Report. The New York hedge fund, led by managing member Ira Unschuld, ended the quarter holding 18,502 shares of Brink's worth roughly $2.16 million and 19,824 shares of SS&C Technologies.
The moves spanned sectors — security, logistics, software, and healthcare — pointing to a broad portfolio rebalancing rather than a bet against any single industry. Other large institutions, meanwhile, moved in the opposite direction, buying into several of the same stocks Brant Point was selling.
Brink's Stake Cut as Analysts Split on the Stock
Brant Point sold 5,000 shares of Brink's during the quarter, leaving it with 18,502 shares worth about $2.16 million. The sale came as analysts sent conflicting signals. On June 8, Weiss Ratings downgraded BCO from a "Hold (C+)" to a "Hold (C)," flagging increased price volatility as a risk. Just days earlier, Goldman Sachs raised its price target on Brink's from $129 to $145 and kept a "Buy" rating, citing the company's shift toward more recurring revenue.
Wall Street Zen went further, upgrading Brink's from "buy" to "strong buy." The split between Goldman's optimism and Weiss's caution sets up a clear test: if Brink's climbs to $145, Brant Point will have sold too early. Institutional investors still own about 95% of Brink's shares, so one fund's exit barely moves the needle on overall ownership.
SS&C and Saia Cuts Draw Little Concern from Wall Street
Brant Point cut its SS&C Technologies (SSNC) stake by 33.5%, down to 19,824 shares, according to Ticker Report. The trim came even as larger institutions, including BlackRock, increased their own exposure to the fintech data company. Analysts view SS&C as a liquid, easy-to-sell stock — the kind funds often tap first when they need cash for other trades.
In Saia (SAIA), Brant Point sold 1,447 shares, leaving it with 14,000 shares worth about $4.57 million — a smaller cut of roughly 9.4%, per Ticker Report. The broader market largely shrugged off the move. JPMorgan raised its Saia price target to $490 with an "overweight" rating. Susquehanna lifted its target to $465 but held a "neutral" rating. Both moves suggest analysts believe the freight market's downturn is close to bottoming out.
Deeper Cuts in Acadia Healthcare and NICE Ltd
Brant Point made its steepest cuts in Acadia Healthcare (ACHC) and NICE Ltd (NICE). In Acadia, the fund sold 30,000 shares — roughly half its position — leaving it with 30,000 shares worth about $2.05 million. Despite the exit, institutional investors hold a striking 98.69% of Acadia's outstanding shares. Selling by one hedge fund barely shifts that picture; it more likely signals that "fast money" is stepping aside for longer-term holders.
In NICE, Brant Point sold 7,958 shares — about 60% of its stake — and ended with just 5,000 shares worth roughly $565,000. On the other side of that trade, Migdal Insurance & Financial Holdings increased its NICE stake by 0.9%, bringing its total to 1,646,690 shares worth about $186.1 million, according to Ticker Report. The Israeli insurer's continued buying suggests local confidence in NICE's AI-driven software business, even as U.S. hedge funds pull back.
Institutions Fill the Gap Brant Point Left Behind
Across all five stocks, the pattern is the same: Brant Point sells, other institutions buy. That dynamic keeps the "institutional floor" — the share of stock held by funds and large investors — intact. For Acadia Healthcare, that floor sits near 99%. Even for NICE, where Brant Point cut deeply, Migdal's $186 million stake dwarfs what Brant Point sold.
The broader takeaway is that Brant Point's moves look more like a defensive rebalancing — raising cash or rotating into other positions — than a fundamental loss of faith in these companies. Goldman Sachs and JPMorgan's continued bullishness on Brink's and Saia only adds to that read. The next quarterly filings will show whether Brant Point reinvested that cash or kept raising it.
Sentiment
Mostly PositiveNEGATIVENEUTRALPOSITIVE
Publishers
15
Articles
8
Reach
23
A
AnonymousAuthor
